Protara Therapeutics, Inc.TARANASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +96.77% | +132.58% | +256.43% | +99.08% | +89.31% |
| Weighted Average Shares Diluted Growth | +96.77% | +132.58% | +256.43% | +99.08% | +89.31% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -100.00% | +1500.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +6.36% | +129.82% | +147.39% | +54.39% | +53.72% |
| Book Value per Share Growth | -45.99% | +5.18% | -23.87% | -21.19% | -14.56% |
| Debt Growth | -16.94% | -18.00% | -19.13% | -20.79% | -22.80% |
| R&D Expense Growth | +29.78% | +48.86% | +19.35% | +68.62% | +17.76% |
| SG&A Expenses Growth | -4.95% | +3.28% | +21.28% | +36.08% | +21.34% |